Profile
Albertien Greijdanus was the founder of Alleviant Medical, Inc. and held the title of Director & Chief Compliance Officer since its founding in 2017.
Ms. Greijdanus is currently a Senior Investment Manager at Brabantse Ontwikkelings Maatschappij Holding BV, starting in 2024.
Education includes an undergraduate degree from Delft University of Technology conferred in 2008 and a graduate degree conferred in 2011.
Albertien Greijdanus active positions
| Companies | Position | Start |
|---|---|---|
Brabantse Ontwikkelings Maatschappij Holding BV
Brabantse Ontwikkelings Maatschappij Holding BV Investment ManagersFinance BOM invests in companies located across the globe primarily in Netherlands. The firm focuses on decentralized energy systems, medtech & life sciences, plant based, deep tech, AI-tech and defense sectors. It participates in early stage capital requirements with an investment size between EUR 0.2 and 5 million. The firm acquires minority interest. | Private Equity Investor | 31/12/2023 |
Former positions of Albertien Greijdanus
| Companies | Position | End |
|---|---|---|
Alleviant Medical, Inc.
Alleviant Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a medical device company developing potential therapies for congestive heart failure | Founder | - |
Education of Albertien Greijdanus
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Delft University of Technology
Delft University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Brabantse Ontwikkelings Maatschappij Holding BV
Brabantse Ontwikkelings Maatschappij Holding BV Investment ManagersFinance BOM invests in companies located across the globe primarily in Netherlands. The firm focuses on decentralized energy systems, medtech & life sciences, plant based, deep tech, AI-tech and defense sectors. It participates in early stage capital requirements with an investment size between EUR 0.2 and 5 million. The firm acquires minority interest. | Finance |
Alleviant Medical, Inc.
Alleviant Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a medical device company developing potential therapies for congestive heart failure | Commercial Services |
- Stock Market
- Insiders
- Albertien Greijdanus
















